Herrmann, O., Kuepper, M. K., Bütow, M., Costa, I. G., Appelmann, I., Beier, F., . . . Schemionek, M. (2019). Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia. BMC Cancer.
Chicago-tyylinen lähdeviittausHerrmann, Oliver, et al. "Infliximab Therapy Together With Tyrosine Kinase Inhibition Targets Leukemic Stem Cells in Chronic Myeloid Leukemia." BMC Cancer 2019.
MLA-viiteHerrmann, Oliver, et al. "Infliximab Therapy Together With Tyrosine Kinase Inhibition Targets Leukemic Stem Cells in Chronic Myeloid Leukemia." BMC Cancer 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.